Table 1.
Community | ANOVA F statistics | ANOVA p value ANOVA | Lowest % of core sampled significantly different from the 100% treatment | |
---|---|---|---|---|
Percentage of metazoan taxa | NA | 4.1 | <0.001 | 1% (0.2 g) |
Number of unique OTUs | Non-Metazoan Eukaryotes | 67 | <0.001 | 85% (24 g) |
Metazoans | 23 | <0.001 | 78% (22 g) | |
Margalef index | Non-Metazoan Eukaryotes | 57 | <0.001 | 71% (20 g) |
Metazoans | 17 | <0.001 | 57% (16 g) | |
ACE richness | Non-Metazoan Eukaryotes | 51 | <0.001 | 78% (22 g) |
Metazoans | 19 | <0.001 | 63% (18 g) | |
PERMANOVA F Statistics | PERMANOVA p value | Lowest % of core sampled significantly different from the 100% treatment | ||
Beta-Diversity | Non-Metazoan Eukaryotes | 2.5 | <0.001 | 43% (12 g) |
Metazoans | 1.9 | <0.001 | 71% (20 g) |
One-way parametric analysis of variance ANOVA was used to test for the effect of sample volume. P values smaller than 0.01 indicate a significant effect of sample volume. Pairwise comparisons between the 100% treatment and the other 13 treatments were performed with the Tukey HSD test. Effects of sample volumes on beta-diversity differences among treatments were tested with PERMANOVA. Differences between the 100% treatment and the other 13 treatments for beta-diversity was tested with PERMDISP. The treatment with the highest sample volume still different from the treatment comprising 100% of the sampled area in each of the variable is presented in the last column of the table.